Clinical Trials Browser

INDUSTRY × ART123 × Clear all

NCT05251727 2024-08-19

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Phase 1 Terminated

Chemotherapy-induced Peripheral Neuropathy

NCT02792842 2024-04-04

Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer

Phase 2 Completed

79 enrolled 10 charts

Gastrointestinal

Postoperative Stage II/III Colon Cancer